“Effectiveness and Safety of Tuberculin Purified Protein Derivative for the Treatment of Anogenital Warts in Patients With Human Immunodeficiency Virus”. Dermatology Reports 16, no. 3 (January 30, 2024). Accessed June 19, 2025. https://journals.pagepress.org/dr/article/view/9754.